These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2475716)

  • 21. Effect of T4-induced cardiac hypertrophy on O2 supply-consumption balance during normoxia and hypoxia.
    Talafih K; Grover GJ; Weiss HR
    Am J Physiol; 1984 Mar; 246(3 Pt 2):H374-9. PubMed ID: 6230939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduction of cardiac hypertrophy in renal hypertensive rabbits with pindolol.
    Cimini CM; Gonzalez MA; Weiss HR
    J Pharmacol Exp Ther; 1991 May; 257(2):541-6. PubMed ID: 1827840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of propranolol and pindolol on plasma ANP levels in humans at rest and during exercise.
    Bouissou P; Galen FX; Richalet JP; Lartigue M; Devaux F; Dubray C; Atlan G
    Am J Physiol; 1989 Aug; 257(2 Pt 2):R259-64. PubMed ID: 2527473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thyroxine-induced cardiac hypertrophy: time course of development and inhibition by propranolol.
    Klein I
    Endocrinology; 1988 Jul; 123(1):203-10. PubMed ID: 2968237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between cGMP and myocardial O2 consumption is altered in T4-induced cardiac hypertrophy.
    Weiss HR; Rodriguez E; Tse J
    Am J Physiol; 1995 Feb; 268(2 Pt 2):H686-91. PubMed ID: 7864195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of myocardial alpha 1- but not beta-adrenoceptors after 90-day tail-suspension.
    Chen J; Zhang LF; Han C; Yu GS; Ma J
    J Gravit Physiol; 1996 Apr; 3(1):57-62. PubMed ID: 11539308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of 10- to 12-day treatment with L-thyroxine in rats with myocardial infarction.
    Gay RG; Graham S; Aguirre M; Goldman S; Morkin E
    Am J Physiol; 1988 Oct; 255(4 Pt 2):H801-6. PubMed ID: 3177671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myocardial effects of cyclic AMP phosphodiesterase inhibition are dampened in thyroxine-induced cardiac hypertrophy.
    Straznicka M; Leone RJ; Scholz PM; Weiss HR
    J Surg Res; 1998 Apr; 76(1):61-6. PubMed ID: 9695741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac hypertrophy induced by thyroid hormone is independent of loading conditions and beta adrenoceptor blockade.
    Bedotto JB; Gay RG; Graham SD; Morkin E; Goldman S
    J Pharmacol Exp Ther; 1989 Feb; 248(2):632-6. PubMed ID: 2537405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human heart beta-adrenoceptors: beta1-adrenoceptor diversification through 'affinity states' and polymorphism.
    Molenaar P; Chen L; Semmler AB; Parsonage WA; Kaumann AJ
    Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):1020-8. PubMed ID: 17714089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beta-adrenergic control of motility in the rat colon. II. Proportions of beta 1- and beta 2-adrenoceptors identified with 125I-(-)pindolol binding.
    Ek BA; Nahorski SR
    Gastroenterology; 1986 Feb; 90(2):408-13. PubMed ID: 2867002
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of beta-adrenoceptor-mediated relaxation on alpha-adrenoceptor-mediated contraction of rat pulmonary artery to adrenaline or noradrenaline.
    O'Donnell SR; Wanstall JC; Mustafa MB
    J Pharm Pharmacol; 1987 Apr; 39(4):278-82. PubMed ID: 2884291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atypical responses of rat ileum to pindolol, cyanopindolol and iodocyanopindolol.
    Hoey A; Jackson C; Pegg G; Sillence M
    Br J Pharmacol; 1996 Feb; 117(4):712-6. PubMed ID: 8646418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of propranolol-resistant (-)-[125I]-cyanopindolol binding sites in rat soleus muscle.
    Roberts SJ; Molenaar P; Summers RJ
    Br J Pharmacol; 1993 Jun; 109(2):344-52. PubMed ID: 8102926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences between the third cardiac beta-adrenoceptor and the colonic beta 3-adrenoceptor in the rat.
    Kaumann AJ; Molenaar P
    Br J Pharmacol; 1996 Aug; 118(8):2085-98. PubMed ID: 8864547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intrinsic sympathomimetic activity and coronary blood flow.
    Berdeaux A; Giudicelli JF
    Br J Clin Pharmacol; 1982; 13(Suppl 2):175S-180S. PubMed ID: 6125167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical pharmacology of beta-adrenoceptor blocking drugs possessing partial agonist activity, with special reference to pindolol.
    Aellig WH
    J Cardiovasc Pharmacol; 1983; 5 Suppl 1():S16-20. PubMed ID: 6188915
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thyroxine-induced left ventricular hypertrophy in the rat. Anatomical and physiological evidence for angiogenesis.
    Chilian WM; Wangler RD; Peters KG; Tomanek RJ; Marcus ML
    Circ Res; 1985 Oct; 57(4):591-8. PubMed ID: 2412724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of propranolol, pindolol and carteolol on acute regional myocardial ischemia in isolated rabbit hearts.
    Rump AF; Picke D; Rösen R; Klaus W
    Arzneimittelforschung; 1993 Jun; 43(6):641-5. PubMed ID: 8102527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of pindolol and propranolol on beta adrenergic receptors on human lymphocytes.
    Hedberg A; Gerber JG; Nies AS; Wolfe BB; Molinoff PB
    J Pharmacol Exp Ther; 1986 Oct; 239(1):117-23. PubMed ID: 3020227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.